Vrieze et al. (2012) observed a notable improvement in peripheral and hepatic insulin sensitivity in individuals with metabolic syndrome after receiving an infusion of microbiota from lean donors, concluding that intestinal microbiota could be developed as therapeutic agents to increase insulin sensitivity in humans [123]. This evidence concerns the gene INS and metabolic syndrome.